(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 13.79% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.81%.
Twist Bioscience's revenue in 2026 is $409,479,000.On average, 10 Wall Street analysts forecast TWST's revenue for 2026 to be $28,362,715,388, with the lowest TWST revenue forecast at $27,226,263,907, and the highest TWST revenue forecast at $29,225,795,800. On average, 10 Wall Street analysts forecast TWST's revenue for 2027 to be $32,949,620,377, with the lowest TWST revenue forecast at $31,300,053,269, and the highest TWST revenue forecast at $34,355,083,934.
In 2028, TWST is forecast to generate $37,570,151,876 in revenue, with the lowest revenue forecast at $35,272,963,102 and the highest revenue forecast at $39,894,117,314.